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Succinate dehydrogenase (SDH) is a heterotetrameric complex, among which the catalytic core SDHB loss-of-
function mutations lead to mitochondrial enzyme SDH dysfunction and are associated with cancer formation.
However, the impact of SDHB loss on colorectal carcinoma and the underlying mechanisms are largely unknown.
In this study, we found a coherent decreased SDHB expression both in human colorectal cancer (CRC) samples
and CRC cell lines. Combined clinical analysis in a cohort of 43 CRC patients demonstrated a correlation between
reduced SDHB activity and amore advanced clinical phenotype regarding lymphatic and distant metastasis. Applying
genetic interference and cellular function approaches, we found that knocking down SDHB promoted cell migration
and invasion through enabling epithelial-mesenchymal transition (EMT), and inverse results of SDHB overexpression
further confirmed our theory. Mechanical exploration revealed that SDHB knockdown could activate TGFβ signaling
pathway, more precisely through up-regulation of a tight-junction transcriptional repression complex SNAIL1-SMAD3/
SMAD4, thus contributed to the increase in metastasis. In conclusion by identifying SNAIL1-SMAD3/SMAD4 as
essential for the TGFβ-mediated tumorigenic capacity in SDHB-deficient CRC cells, this study revealed a critical
mechanical vulnerability for potential future therapeutic target of SDHB-associated CRC.
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Colorectal cancer (CRC) is the third most common malignant disease
in men and the second in women worldwide and its prevalence and
mortality continued to climb up across the Asia-Pacific region [1].
Although neoadjuvant treatments kept on developing in last decade,
stacking evidences have shown that high financial cost, chemoresistance
and high toxicity severely constrained the therapeutic efficacy [2].
Therefore it is always welcoming for scientists to identify new
biomarkers of advanced CRC and set up therapeutic strategy rooted
from inspiring researches. Recent discoveries have brought forward that
altered metabolism in malignant cells could serve as an underlying
hallmark of neoplastic transformation [3].
The tricarboxylic acid (TCA) cycle is a central metabolic pathway that
supplies pivotal source for mitochondrial NADH and many anabolic
precursors [4]. Oncogenic mutations in TCA-cycle-related enzymes such
as SDH have been identified to be a predisposing factor in various cancers
[5]. Succinate dehydrogenase (SDH) is a mitochondrial metabolic
enzyme responsible for the oxidation of succinate to fumarate in the citricacid cycle and its associated electron transport [6]. SDHB is the catalytic
core component of heterotetrameric complex SDH, of which
loss-of-function mutations lead to enzymatic dysfunction and are
associated with cancer formation mostly reported in hereditary
paragangliomas to date [7]. Although SDH generally displayed tumor
suppressor properties to some extent [8], the impact of enzymatic subunit
SDHB on colorectal tumors and how impaired bioenergetic and anabolic
synthesis influenced cellular function remained largely unresolved.A
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which causes accumulation of succinate, acting as a competitive
inhibitor of the hypoxia-inducible factor (HIF) prolyl-hydroxylases
[9]. This stabilization of HIF-alpha elicits a pseudohypoxic
phenotype, activating genes that facilitate angiogenesis and anaerobic
metabolism. So far, HIFs are the only mechanism reported linking
SDHB-mutation to carcinogenesis, which have also been described
insufficient comprehensively. Therefore a more profound under-
standing of SDHB-related tumorigenesis is crucial.
In this study, we discovered a ubiquitously low SDHB activity in
colorectal carcinoma. By generating SDHB-knockdown and overex-
pression stable CRC cell lines and using analytical functional
approaches to identify various levels of adaptations subsequent to
SDHB loss. We found that lack of SDHB activity commits cells to
epithelial-mesenchymal transition (EMT), which sustains CRC cell
invasion and metastasis. Clinical assessment revealed a correlation
between low SDHB expression and more advanced phenotype with
poorer prognosis, corroborating our theory. We further demonstrated
that SDHB deficiency activates TGFβ signaling [10] and thus triggers
a transcriptional repression complex SNAIL1-SMAD3/SMAD4,
previously documented to bind to several cell tight-junction related
genes promoter area, consequently mobilizing malignant CRC cells
[11]. By unraveling that SNAIL1-SMAD3/SMAD4 complex is
critical for the TGFβ-dependent invasion in SDHB-deficient CRC
cells, we revealed a new essential signal pathway other than HIFs,
which could offer new therapeutic targets for SDHB mutation driven
metabolically abnormal late-stage and metastatic CRC patients.
Materials and Methods
Cell Culture
Colorectal cancer cell line HT-29, SW480, SW620, SW1116 and
normal colorectal epithelial cell line NCM460 were purchased from
Cell Bank of Chinese Academy of Sciences. HT-29 and NCM460
cells were cultured in Dulbecco's modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/
ml) and streptomycin (100 μg/ml) and were incubated at 37 °C in a
humidified incubator under 5% CO2 condition.
SW480, SW620, SW1116 cells were cultured in L-15 medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin
(100U/ml) and streptomycin (100 μg/ml) and were incubated at 37 °C
in a humidified incubator under 0.038% CO2 condition.
Immunohistochemical Staining (IHC)
Wehave obtained paraffin-embeddedCRCand adjacent normal tissue
specimens from the Division of General Surgery at Zhongshan hospital.
Formalin-fixed paraffin-embedded (FFPE) 6 mm sections were used for
IHC. SDHB primary antibody (proteintech, cat# 10,620–1-AP, 1:50
dilution) was incubated overnight at 4 °C. Immunostaining was
performed using diaminobenzidine reaction and controlled under
microscope. Hematoxylin was used for counterstaining.
Quantitative Real-Time PCR
Total RNA was extracted from cultured cells using Trizol reagent
(Invitrogen, Carlsbad, CA) and dissolved in diethylpyrocarbonate
treated (DEPC) water. cDNA was synthesized using the Takara
Reverse Transcription System Kit (Takara Biotechnology Co. Ltd.,
Japan) according to the manufacturer's instruction. Real time
quantitative RT-PCR was performed using the Sybr green premix kit
(BioRad, Hercules, CA, USA). GAPDH was used as a housekeepinggene. The following primers are used in this assay: SDHB: sense
GACACCAACCTCAATAAGGTCTC, and anti-sense GGCTCAAT
GGATTTGTACTGTGC; Snail1: sense TCGGAAGCCTAACTAC
AGCGA, and anti-sense AGATGAGCATTGGCAGCGAG; Smad3:
sense CCATCTCCTACTACGAGCTGAA, and anti-sense CACTG
CTGCATTCCTGTTGAC; Smad4: sense CTCATGTGATCTATG
CCCGTC, and anti-sense AGGTGATACAACTCGTTCGTAGT;
ZO1: sense ACCAGTAAGTCGTCCTGATCC, and anti-sense TCG
GCCAAATCTTCTCACTCC; E-cadherin: sense CGAGAGCTACA
CGTTCACGG, and anti-senseGGGTGTCGAGGGAAAAATAGG;
N-cadherin: sense TGCGGTACAGTGTAACTGGG, and anti-sense
GAAACCGGGCTATCTGCTCG; Fibronectin: sense CGGTGGCT
GTCAGTCAAAG, and anti-sense AAACCTCGGCTTCCTCCA
TAA; GAPDH: sense ACAACTTTGGTATCGTGGAAGG, and anti-
sense GCCATCACGCCACAGTTTC.
SDHB shRNA Transfection
SDHB shRNAs were obtained from Institute of Biochemistry and
Cell Biology, SIBS, CAS. A scrambled sequence was also purchased as
control. Cell transfection was performed with PEI reagent (Sigma-Al-
drich, MO, USA).
Matrigel Invasion Assay
For transwell invasion assay, 50 μl matrigel (BD Bioscience,
Franklin Lakes, NJ, USA) was added into top chamber for 30 minutes
at 37°C. After starvation in serum free medium for 24 hours and cells
were seeded at 1 × 104 cells/well to the top chambers. The bottom
chambers were filled with completed medium. Any non-invading cells
remaining in the top chamber were removed carefully with a swab in 48
hours culturing. Cells adhering to the lower membrane of the well were
fixed in methanol and stained with crystal violet, and finally counted
under 200× magnification. Crystal violet staining was dissolved in 33%
acetic acid and optical density was detected at 570 nm.
Western Blotting
Equal amounts of protein were separated by 10% SDS polyacryl-
amide gel electrophoresis and transferred to PVDF membranes. After
blocking with 5% non-fat milk in TBST for 1 hour, membranes were
incubated overnight at 4 °Cwith SDHB ,GAPDH, SNAIL1, SMAD3,
SMAD4, E-cadherin, N-cadherin primary antibodies followed by
incubation with HRP-conjugated secondary antibodies. Immunoreac-
tive bands were developed with enhanced chemiluminescent HRP
substrate (Millipore, Bollerica, MA, USA).
Luciferase Assay
Transfections were performed using LipofectAMINE-2000 (Invitro-
gen, Carlsbad, CA, USA) as per the manufacturer's instructions. Relative
luciferase activity was detected with dual luciferase kit (Promega E1906)
as per the manufacturer's instructions and calculated as the ratio of
luciferase/renilla activity.
Succinate Detection
Succinate level was detected using Succinate Colorimetric Assay
Kit (Sigma-Aldrich, MO) as per the manufacturer's instructions.
Succinate level is measured as nmol/mg protein.
Statistical Analysis
Statistical analyses were performed using SPSS 21.0 (IBM,
Chicago, IL, USA). chi-Squared test was used for analyzing relations
between clinical parameters and SDHB expression levels. Student's t
Figure 1. SDHB expression is low in CRC cell lines. (A) Quantitative RT-PCR analysis of SDHB expression in four CRC cell lines and normal
colorectal epithelial cell line NCM460. (B) Semi- quantitative RT-PCR analysis of SDHB expression in four CRC cell lines and normal
colorectal epithelial cell line NCM460. (C) Western blotting analysis of SDHB protein expression in four CRC cell lines and normal
colorectal epithelial cell line NCM460.
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statistically significant under .05.
Results
SDHB Expression is Ubiquitously Low in CRC Cell Lines and
in the Samples of CRC Patients
SDHB is the key enzymatic component of mitochondrial enzyme
SDH constructively expressed across species, which oxidizing
succinate to fumarate in the TCA cycle and feeding electrons intoFigure 2. SDHB expression is low in CRC tissues. (A) Quantitative RT-P
its corresponding normal tissues. (B) Representative immunohistoch
SDHB in 43 pair of CRC samples. (C) Succinate level was detected with
corresponding normal tissues.the mitochondrial respiratory chain for ATP production. We
examined SDHB mRNA and protein level in four CRC cell lines
and normal colorectal epithelial cell line NCM460. As shown in
Figure 1 both SDHB mRNA level and protein level was relatively low
in all four CRC cell lines (SW480, SW620, SW1116, and HT-29),
compared to non-CRC epithelial NCM460 cells. For further
confirmation, we detected SDHB mRNA expression in 29 pairs of
CRC and adjacent noncancerous tissues by quantitative RT-PCR. As
shown in Figure 2A, CRC tissues exhibited remarkably reduced
SDHB mRNA level compared to corresponding normal tissues.CR analysis of SDHB expression in 29 pairs of colorectal tumor and
emistry images showed varied but unanimously low expression of
colorimetric assay at 450 nm in 29 pairs of colorectal tumor and its
Figure 3. SDHB knockdown promoted invasion in CRC cell line HT-29. (A) Matrigel invasion assay showed that SDHB knockdown
strengthened invasive capacity. (B) Absorbance at 570 nm showed quantitative matrigel invasion data after 24 hours. P b .05. (C)
Quantitative RT-PCR analysis of knockdown efficiency in SDHB shRNA transfected stable cell lines. (D) Western blotting analysis of
knockdown efficiency in SDHB shRNA transfected stable cell lines. (E) MTT assay showed SDHB knockdown had no remarkable effect on
cell proliferation.
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And as expected, reduced SDHB level in CRC tissues led to impaired
succinate activity and subsequent succinate accumulating (Figure 2C).
Conclusively, SDHB expression is generally down regulated in CRC
and we have noticed a certain extent of heterogeneity among patients,
which could indicate specific biological functions under pathological
settings.
SDHB Knockdown Promotes Invasion of CRC Cells
Recent studies have shown that SDHB deletion completely
truncates TCA cycle and diverts cells to glycolysis to fulfill energetic
needs. We wondered that how this major metabolic rewire affect
cellular performance functionally. Based on previous finding that
HT-29 harbored relative higher expression of SDHB, we
constructed SDHB knockdown stable cell line through lentiviral
infection. Once we excluded the possible effects that SDHB
knockdown exerted on CRC cells proliferation (Figure 3E), which
was not apparent, it became crystal clear that decreased expression
of SDHB enhanced invasive capabilities in HT-29 cells (Figure 3,
A and B), illustrated by matrigel assay. SDHB knockdownefficiency was confirmed on both mRNA and protein level (Figure
3, C and D).
SDHB Overexpression Inhibits Invasion of CRC Cells
For further validation, we also constructed SDHB overexpression
stable cell line in SW1116 and performed corresponding experiments.
Results came in coherent with our previous loss-of-function data
(Figure 4), that SDHB overexpression suppressed CRC cells invasive
and migratory capability (Figure 4, A and B). All in all, that SDHB
had a fundamental role in cellular motility and adhesion during CRC
oncogenesis in vitro.
SDHB Knockdown Encourages Epithelial-Mesenchymal
Transition (EMT) in CRC Cells
EMT is a biological process that converts epithelial cells to motile
mesenchymal cells, which was utilized by cancer cells to enhance invasive
and migratory ability, and to acquire stem-like characteristics as
chemoresistance. EMT is defined by the loss of epithelial marker
E-cadherin and the gain of mesenchymal marker N-cadherin alongside
the morphology conversion. Therefore, we examined the influence of
Figure 4. SDHB overexpression inhibited invasion in CRC cell line SW1116. (A) Matrigel invasion assay showed that SDHB overexpression
decreased invasive capacity. (B) Absorbance at 570 nm showed quantitative matrigel invasion data after 24 hours. P b .05. (C)
Quantitative RT-PCR analysis of overexpression efficiency in SDHB virus transfected stable cell lines. (D) Western blotting analysis of
overexpression efficiency in SDHB virus transfected stable cell lines. (E) MTT assay showed SDHB overexpression had no remarkable
effect on cell proliferation.
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A andB, SDHB knockdown decreased E-cadherin, ZO-1 expression and
increased N-cadherin, Fibronectin expression, otherwise stated that
SDHB knockdown greatly promoted EMT. Coherently, SDHB
overexpression had opposing effects (Figure 5, C and D).
SDHB Knockdown Cctivated TGFβ Signaling Pathway and
its Subsequent up Regulation of Transcriptional Repression
Complex SNAIL1-SMAD3/4 Induced EMT
Despite the fact that various levels of EMT regulations have been
subjected to intense research, the role of metabolic enzymes in the
maintenance of EMT has not been extensively studied. Utilizing a
dual luciferase screening system, we discovered a hyperactivated
TGFβ signaling pathway upon SDHB knockdown (Figure 6A),
which was significantly repressed when SDHB is overexpressed
(Figure 6B). In light of this, we proceeded to identify a more precise
mechanism linking the lack of SDHB activity to EMT enhancement.
It has been reported that SNAIL1-SMAD3/4 could bind to severalcellular tight-junction genes promoter region including E-cadherin to
transcriptionally repress genetic expression thus facilitating invasiveness,
which we sought to verify in this context. As expected, knockdown of
SDHB resulted in a drastic increase in SNAIL1-SMAD3/4 mRNA and
protein level (Figure 6, C and D). Matrigel transwell assay was
performed in the case of adding mouse SDHB, TGFβ inhibitor
SB-431,542 and SMAD4shrna. Results demonstrated that adding
mouse SDHB, TGFβ inhibitor SB-431,542 and SMAD4shrna could
all partially restored SDHB-deficient impelled invasive phenotype,
among which the last had themodest effect. This phenotypic rescue was
accompanied with an up regulation of epithelial marker E-cadherin and
down regulation of mesenchymal marker N-cadherin as well as
SNAIL1-SMAD3/4, confirming our hypothesis (Figure 6E). Clinical
research also substantiated our findings by elaborating a close
correlation between SDHB expression level and EMT marker and
SNAIL1-SMAD3/4 expression in a cohort of 29 CRC patient samples
(Figure 6F). In conclusion, these results showed that mitochondrial
enzyme SDHB could emerge as critical regulators of tumor
Figure 5. SDHB expression level regulated epithelial-mesenchymal transition (EMT) in CRC cell line. (A) Quantitative RT-PCR analysis
showed that SDHB knockdown advanced EMT, as in down-regulation of epithelial markers and simultaneously up-regulation of
mesenchymal markers. (B) Western blotting analysis showed that SDHB knockdown advanced EMT. (C) Quantitative RT-PCR analysis
showed that SDHB overexpression suppressed EMT, as in up-regulation of epithelial markers and simultaneously down-regulation of
mesenchymal markers. (D) Western blotting analysis showed that SDHB overexpression suppressed EMT.
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in malignant cells, which was at least partly enabled by an aberrantly
active TGFβ signaling pathway.
SDHB Expression is Negatively Correlated With Metastasis
and Prognosis in CRC
Although our studies have verified lower level of SDHB in CRC
samples compared to adjacent non-tumorous tissues, its relevance with
clinical outcomes remained elusive. Combining tissue microarray data
of 43 pairs of CRC specimens including corresponding normal
colorectal mucosal tissues with accurate clinical records analysis, we
were able to unveil that SDHB expression level was negatively correlated
with CRCmetastasis and advanced pathological TNM stage (Table 1).
Conclusively, SDHB could function as a potential biomarker and even
an independent prognostic factor for metastatic CRC.
Discussion
It has come to the senses of many scientists that metabolic
reprogramming is an emerging hallmark during CRC, among
which alterations in TCA were delineated first and the most widely
known [12]. Documented 100 years ago, Warburg effect was
characterized by enhanced glycolysis in the presence of oxygen to
meet the substantially augmented energetic need in tumors [13]. In
fact, discoveries that germline mutations of TCA intermediate
enzymes namely fumarate hydratase and succinate dehydrogenaseresulted in familial paraganglioma and pheochromocytoma syndrome
have come forth in the past decade, supporting Warburg Effect [14].
SDH genes comprise four subunits (SDHA, B, C, D), also known as
complex II of mitochondrial respiratory chain, located at inner
mitochondrial membrane, oxidizing succinate to fumarate. SDHA
and SDHB are the enzymatic cores of SDH heterotetrameric
complex. SDHB mutation inactivates SDH enzyme and causes
cellular succinate to build up, which is now considered oncometa-
bolites, acting manifoldly including partly through the aberrant
epigenetic reprogramming [15]. However, the role of SDHB in other
tumors apart from reported endocrine-associated carcinomas,
remained elusive, let alone how metabolic consequences of disabling
SDH impacts on cellular function and the molecular mechanisms
supporting it. We endeavored to fill up this void in CRC by
demonstrating that SDHB expression is unanimously low in CRC
patients, which is even lower in late-stage CRC patients. In vitro
studies confirmed that knockdown SDHB mobilized CRC cells,
whereas SDHB overexpression hindered its invasive capability. By
supervising CRC cell phenotype comprehensively, we observed that
SDHB deletion conferred a metastatic advantage in CRC, via
significantly boosting EMT. In vitro experiments in accordance with
our clinical analysis have clearly indicated an anti-metastatic role of
SDHB in CRC, which represents a crucial link between glucose
metabolism and tumorigenesis.
Figure 6. SDHB knockdownpromoted TGFβ signal pathway in CRCcells, which activated EMT through positivemodulation of SNAIL1-SMAD3/
4 complex. (A) Dual luciferase assay showed that SDHB knockdown promoted TGFβ signaling in HT-29 cells. CAGA and SBE are the promoter
plasmids commonly used representing TGFβ signal pathway activity. (B) Dual luciferase assay showed that SDHB overexpression attenuated
TGFβ signaling inHT-29 cells. (C)QuantitativeRT-PCRassay showed that SDHBknockdownenhanced transcription factor SNAIL1 expression as
well as TGFβ signaling marker gene SMAD3/4 expression in HT-29 cells. (D) Western blotting showed that SDHB knockdown enhanced
transcription factor SNAIL1 expression as well as TGFβ signaling marker gene SMAD3/4 expression in HT-29 cells. (E) Matrigel invasion assay
showed that the addition of murine SDHB, TGFβR1 inhibitor SB-431,542 and SMAD4shRNA could all rescue human SDHB knockdown
phenotype, amongwhich the last had themodest effect.Western blotting showedexpression levels of SDHBandEMTmarker genes alongwith
SNAIL1-SMAD3/4 complex in the process accordingly. (F) Quantitative RT-PCR analysis showed that the expression of SDHB is significantly
correlated with that of EMT marker genes and SNAIL1-SMAD3/4 complex in 29 pair of CRC tissues (P b .05, Student's t test).
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Table 1. Clinicopathologic correlation of Sdhb expression in human sporatic colorectal carcinoma
Sdhb
Feature Low High χ2 P value#
All cases 21 22
Gender 0.239 .625
Male 13 12
Female 8 10
Age 0.196 .658
N65 11 13
≤65 10 9
Intravascular cancer embolus 6.435 .011
Present 9 2
Absent 12 20
Perineuronal invasion 5.880 .015
Present 7 1
Absent 14 21
Tumor stage
I 1 5 9.119 .028
II 3 9
III 11 6
IV 6 2
The median expression level was used as the cutoff. Low expression of Sdhb in 21 patients was classified
as values below the 50th percentile. High Sdhb expression in 22 patients was classified as values at or above
the 50th percentile.# For analysis of correlation between Sdhb and clinical features, Pearson's chi-square tests
were used. Results were considered statistically significant at P b 0.05.
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chain dysfunction and hypoxia inducible factors (HIFs) stabilization
with a subsequent state of pseudohypoxia [16]. Although this could
lead to enhanced angiogenesis and contribute to oncogenesis [17], it
doesn't account for all the phenotypic transformations and the
underlying mechanisms is open for further exploitation. In this study,
with a dual luciferase screening system, we were able to reveal a critical
role of TGFβ in SDHB-loss-associated EMT [18]. Following
mechanism study depicted that SDHB knockdown significantly
increased pivitol EMT transcription factor SNAIL1 [19] expression as
well as classical TGFβ pathway modulators SMAD3/4 [20]
expression in CRC cells. SNAIL1 has been previously reported in
breast cancers to interact with SMAD3/4, which then targeted to the
gene promoters of multiple tight-junction proteins namely
E-cadherin and acted as co-repressors thus drive EMT. Our study
proposed a similar role for transcriptional repressor complex
SNAIL1-SMAD3/4 under SDHB-deficient circumstances in CRC. In
consistent with this, either adding TGFβ inhibitor or SMAD4shRNA to
SDHB-silenced CRC cells could partly inhibited the bolstered EMT
process and the comparativemilder effect of SMAD4shRNAmay ascribe
to its relative downstream position in TGFβ transduction conduit.
Moreover, loss of SDHB correlated with epithelial marker and
SNAIL1-SMAD3/4 in a cohort of CRC patients. On top of all above,
rather than act solely and independently, it is also possible that TGFβ
[21] and HIFs [22] synergize and interwind since them both has been
implicated in chronic inflammatory microenvironment and could both
produce cytokines like interleukin superfamily.
Taken together, we demonstrated that SDHB knockdown
conferred metastatic advantages on CRC cells leastways through
positive modulation of transcriptional repressor complex SNAIL1-
SMAD3/4. Most cancer-related deaths are caused by metastasis, the
disseminated cancer cells relocated and colonized in distant organ
sites, where our insights are still limited. Therefore, our SDHB
finding linking de novo TCA to tumor motility is especially
beneficial since SDHB is broadly expressed rather than confining tospecific diseases, indicating an extensive application once further
verified. Along the years, the biphasic nature of the TGF-β signaling
pathway during tumorigenesis largely hinders its utilization in
clinical treatment. Thus, disclosing specific downstream effectors
of TGF-β tumor-progressing arm while avoiding the tumor-
suppressing arm allows for accurate CRC treatment. This discovery
holds the promise of resolving unsettled problems and yield
innovative therapeutics when targeting colon cancer metabolic
vulnerabilities.
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